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of Disease
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The most common clinical suppurative lung conditions in children are empyema, lung 
abscess, and bronchiectasis, and to a less often necrotizing pneumonia. Until recently, 
bronchiectasis was the most common form of persistent suppurative lung disease 
in children. Protracted bacterial bronchitis is a newly described chronic suppurative 
condition in children, which is less persistent but more common than bronchiectasis 
(1). In addition, the term “chronic suppurative lung disease” has been used recently to 
describe the clinical features of bronchiectasis when the radiographic features needed 
to make a diagnosis of bronchiectasis are absent. Webster’s New College Dictionary 
defines suppuration as the process of forming and/or discharging pus. Pus is a body 
fluid resulting from intense inflammation in response to infection that leads to neutrophil 
influx and apoptosis, microbial clearance, and often necrosis of nearby tissue. Pus is 
primarily composed of white blood cell debris.
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HiSTORY
Pus has received written commentary since the first recorded medical works. Prescriptions for drain-
ing pus from abscesses were found in the Egyptian Medical Papyri (1550 BC) (2) and Hippocrates 
(430 BC) described empyema in several of his writings (3, 4). By the early 1800s, bronchiectasis, 
empyema, and lung abscess were recognized clinical entities associated with purulent secretions 
noted on autopsy but not yet linked to infection (5). In the latter half of the nineteenth century, the 
association of bacteria and infection with these entities evolved. In the 1870s, Pasteur reported that 
microorganisms were found in pus and were necessary to cause purulent infections (6). By the end of 
the nineteenth century, textbooks of bacteriology classified the “pyogenic bacteria” (Staphylococcus 
aureus and Streptococcus pyogenes), and noted that the most common cause of lobar pneumonia 
was pneumococcus (7). In the first quarter of the twentieth century, before the development of 
antibiotics, radiographic imaging became a standard diagnostic tool, which revolutionized the 
diagnosis of pneumonia, lung abscess, and pleural disease (8). In the 1800s, bronchiectasis was most 
often associated with sequelae of then common infectious diseases, including pertussis, measles, 
and tuberculosis, or due to the long-term effects of retained airway foreign bodies (9). Over the past 
50 years, with the advent of vaccinations, improved nutrition, public health services, environmental 
Abbreviations: ABPA, allergic bronchopulmonary aspergillosis; CF, cystic fibrosis; CSLD, chronic suppurative lung disease; 
HRCT, high-resolution computerized tomography; PBB, protracted bacterial bronchitis; PCD, primary ciliary dyskinesia.
TabLe 1 | Mechanisms of poor clearance of infection and pus in children.
External compression Hilar adenopathy
Tumors, cysts
Vascular rings and slings
Endobronchial obstruction Foreign body aspiration
Endobronchial granuloma
Poor airway stability Tracheo- and bronchomalacia (including TE 
fistula repair)
Congenital pulmonary airway 
malformations
Bronchial atresia, bronchial stenosis
Congenital cystic adenomatoid malformation
Intralobar sequestration, bronchogenic cyst
Micro-aspiration Dysphagia syndromes
Laryngeal cleft, TE fistula
Impaired cough Neuromuscular weakness, impaired threshold 
to cough
Impaired cilia function Cystic fibrosis (CF), ciliary dyskinesias
Impaired immune system B-cell deficiencies (IgG deficiencies, IgG 
subclass deficiencies, IgA deficiencies), chronic 
granulomatous disease, combined variable 
immunodeficiency, and T-cell deficiencies
Abnormal mucus rheology CF, ciliary dyskinesias
Postinfectious bronchiectasis
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awareness of indoor pollutants, and antibiotics/antifungal thera-
pies, the prevalence of bronchiectasis has significantly decreased. 
It is now considered relatively uncommon in developed countries, 
though it still remains a significant cause of morbidity.
PaTHOPHYSiOLOGY
The common themes of the suppurative pulmonary conditions 
are persistent and recurrent infection, intense neutrophilic 
inflammation, and poor clearance of infected material. Classic 
suppurative lung diseases are characterized by pus observed 
in expectorated sputum or sampled with drainage procedures 
through pleural catheters and with bronchoalveolar lavage.
Persistent inflammation becomes destructive but is often 
compartmentalized to a lung region. Lung abscesses are usually 
thick-walled localized regions; bronchiectasis, even in children 
with CF, occurs with only patchy peribronchiolar pneumonitis 
and could be considered an endobronchial abscess (10). Sepsis 
rarely occurs in children as a consequence of lung abscesses or 
bronchiectasis.
Predisposing Factors
Poor pulmonary clearance of infected fluid is common; 
multiple mechanisms for this are listed in Table 1 along with 
some clinical examples. Recurrent aspiration in the presence of 
impaired host defense and/or tissue injury leads to recurrent 
and persistent airway infection. Poor oral hygiene and gingival 
disease contribute to this process in children with neurologic 
impairments and in children who aspirate following viral lower 
tract infections (11, 12). Children with postinfectious bronchi-
ectasis have persistent colonization of their nasopharynx for 
years with the organisms isolated from expectorated sputum 
and bronchoalveolar lavage (13).
Bronchiectasis is exacerbated by chronic exposure to environ-
mental irritants and pollution. Tobacco and biomass (cooking 
fuel) smoke, ozone, and sulfur dioxide all increase goblet cell 
and submucosal gland mucus output (14). Sustained tobacco 
smoke exposure also increases goblet cell number and density in 
the airways, remodeling the airway into a hyper-secretory state. 
Bronchiectasis can also result from a “vicious cycle” of airway 
infection, as with lower respiratory tract viral infections, leading 
to airway injury, which is exacerbated by subsequent infections 
(15). Recurrent viral respiratory infections are more common with 
household crowding and daycare attendance and are associated 
with bronchiectasis in indigenous populations (16). Worldwide, 
malnutrition also plays a role by impairing host defenses. Of the 
immune deficiencies encountered in children presenting with 
bronchiectasis, B-cell disorders accounted for 73% of 131 chil-
dren in a large case series (17). Of these, IgG deficiency accounted 
for two thirds of the cases. T-cell disorders (hyper-IgE syndrome, 
ataxia–telangiectasia, and Wiskott–Aldrich syndrome) accounted 
for only 7%.
airway Microbiology
The pathogens that produce suppurative lung disease in children 
include aerobic and anaerobic bacteria and, less frequently, 
fungi. Viruses may cause diffuse or patchy pneumonitis noted 
radiographically, but pus is rarely described. However, viruses 
such as adenovirus are known to cause bronchiolitis obliterans 
which in turn is complicated by bronchiectasis (18). The bacte-
rial pathogens vary depending on the underlying specific clinical 
disorder (Table  2). Exceptions to this list include age-specific 
pathogens in the newborn period, e.g., Gram-negative organisms 
and group-B streptococcus. Fungal abscesses are more common 
in immunosuppressed patients, including those with oncological 
disorders and transplantation recipients. Children with immu-
nodeficiencies, e.g., X-linked agammaglobulinemia and hyper-
IgE syndrome, are predisposed to recurrent Staphylococcal 
infections, which can lead to lung abscess and chronic airway/
parenchymal damage. Both aerobic and anaerobic bacteria 
have been isolated from lung abscesses in children (19). Among 
neurologically impaired children who underwent transtracheal 
aspiration to diagnose aspiration pneumonia, 67 of 74 (90%) 
aspirates grew both aerobic and anaerobic bacteria. Aspergillus 
infection complicates bronchiectasis in children with asthma and 
cystic fibrosis (CF) and can cause lung abscesses in immunocom-
promised patients.
Of note, the presence of Pseudomonas aeruginosa isolated 
from airway cultures of children and adults with CF and adults 
with idiopathic bronchiectasis is associated with more rapid 
lung function decline and increased morbidity compared to 
those without Pseudomonal infection (22, 23). The age of initial 
isolation of Pseudomonas from sputum and/or bronchoalveolar 
lavage is much earlier in children with CF compared to children 
and young adults with postinfectious bronchiectasis and primary 
ciliary dyskinesia (PCD) (24–26). Among 68 infants with diag-
nosed CF undergoing surveillance bronchoalveolar lavage, 18% 
had Pseudomonas isolated by 2 years of age (26). In a separate 
prospectively studied cohort, 82 of 155 (53%) children with CF 
had Pseudomonas isolated by the time they reached 5 years of age 
(24). In contrast, 3 of 113 (2.7%) children 3 months to 16 years 
of age with newly diagnosed bronchiectasis unrelated to CF had 
TabLe 2 | Microorganisms isolated from patients with bronchiectasis.
Cystic fibrosis Chronic aspiration (11) Postinfectious 
bronchiectasis (15)
immotile cilia (20) Lung abscess (21)
Pseudomonas aeruginosa Alpha hemolytic streptococcus Haemophilus influenzae non-
type b
H. influenzae non-type b Oral flora
Staphylococcus aureus 
(including MRSA)
Staphylococcus aureus Streptococcus pneumoniae Staphylococcus aureus Staphylococcus aureus
Stenotrophomonas maltophilia Streptococcus pneumonia Moraxella catarrhalis Streptococcus pneumoniae P. aeruginosa
Burkholderia cepacia complex Peptococcus Staphylococcus aureus M. catarrhalis Proteus mirabilis
H. influenzae non-type b Peptostreptococcus P. aeruginosa (adults) Aspergillus species
Achromobacter Fusobacterium Anaerobic organisms
Non-tuberculous mycobacteria Bacteroides melaninogenicus
Veillonella
P. aeruginosa
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FiGuRe 1 | episodes of acute pneumonia per child year produced in 2007 by the Child Health epidemiology Reference Group, established by the 
world Health Organization. Reproduced with permission from Rudan et al. (38) and the World Health Organization.
>104 CFU/ml of Pseudomonas isolated from bronchoalveolar lav-
age samples (27). Similarly, among 118 children 2–24 years of age 
with PCD, mucoid and non-mucoid Pseudomonas were recovered 
from 3 and 6%, respectively (20). Pseudomonas airway infection 
is often persistent in CF, PCD, and idiopathic bronchiectasis in 
adults and requires more aggressive and recurrent treatment than 
other bacterial pathogens.
airway Microbiota
Recent descriptions of lower airway microbiota in children 
and adults with CF- and non-CF-related bronchiectasis have 
provided new insights about these conditions. Characterizing 
populations of aerobic and anaerobic bacteria in the lung using 
culture-independent techniques such as nucleic acid sequencing, 
the lung is no longer considered a sterile site. New characteristics, 
such as diversity of lower airway bacterial populations, correlate 
directly with lung function and inversely with cough scores in 
adults with bronchiectasis (28). A decreasing diversity of bacte-
rial populations in the lung is associated with more severe airway 
obstruction. Also, in a recent report comparing the lower airway 
microbiomes of 56 children 2–13  years of age with protracted 
bacterial bronchitis (PBB), bronchiectasis, and CF, the degree 
of diversity and the species membership of the core microbiota 
were remarkably similar across disease groups, the most common 
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FiGuRe 3 | Percentage of households using solid fuel for cooking in 2000 according to the world Health Organization. Reprinted with permission of the 
American Thoracic Society. Reproduced from Copyright © 2016 American Thoracic Society. The Proceedings of the American Thoracic Society is an official journal 
of the American Thoracic Society. It was renamed the Annals of the American Thoracic Society in 2013 (40).
FiGuRe 2 | Cigarette consumption (#cigarettes smoked per person per year among adults) compiled by the Tobacco atlas in 2015. Reproduced with 
permission from Copyright Clearance Center license #3981000761719.
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FiGuRe 4 | Percentage of children <5 years old who are underweight produced by the Center of international earth Science information Network in 
2005. Reproduced with permission from Center for International Earth Science Information Network (CIESIN), The Earth Institute, Columbia University (41).
of which were shared with microbiota of sampled from normal 
children (29). The results differed from reports of microbiomes of 
adults with advanced airway disease suggesting the microbiome 
transitions in disease specific ways with time, treatment, and 
progression of disease.
SPeCiFiC CHRONiC SuPPuRaTive 
CONDiTiONS
Bronchiectasis is defined by the abnormal appearance of the 
conducting airways by high-resolution computerized tomogra-
phy (HRCT) of the chest, producing dilation, thickened airway 
walls, and saccular changes in the clinical setting of chronic wet 
cough with or without expectoration of mucopurulent sputum. 
Bronchiectasis can be diagnosed in some chest radiographs, but 
this is an insensitive way to make the diagnosis and is not con-
sidered the gold standard. Bronchiectasis is the result of chronic 
airway infection leading to loss of structural integrity of the 
airway wall, which produces airway dilation. It can occur focally 
after serious acute respiratory infections or with post-obstructive 
pneumonia due to foreign body or endobronchial lesions (tumor 
and tuberculosis) or throughout the lung in a patchy distribu-
tion (e.g., CF and PCD). Bronchiectasis can also develop after 
severe lower respiratory viral infections, especially in indigenous 
populations (18, 30). Bronchiectasis results in airway dilation, 
described as cylindrical or saccular in shape, diagnosed by HRCT. 
The relatively increased size of the airway lumen compared to its 
neighboring pulmonary artery produces a “signet ring” appear-
ance, diagnostic of bronchiectasis. However, the normal ratio 
of the airway to the vessel diameter is age dependent in normal 
children (31).
Protracted bacterial bronchitis is a recognized entity encoun-
tered primarily in young children. It is defined by a “wet” cough 
lasting longer than 1 month. It is likely a precursor to bronchi-
ectasis in some cases, but it can be completely eliminated with 
two to three prolonged courses of antibiotic treatment (32). 
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FiGuRe 5 | Tuberculosis cases in adults and children per 100,000 populations in 2007 compiled by the world Health Organization. Reproduced with 
permission from World Health Organization Map Production: Public Health Information and Geographic Information Systems (GIS) World Health Organization.
FiGuRe 6 | Hiv disease prevalence in 2007 compiled by the world Health Organization. Reproduced with permission from WHO/UNAIDS Map Production: 
Public Health Information and Geographic Information Systems (GIS) World Health Organization.
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Children with PBB are often too young to expectorate sputum 
even though they present with a “wet” cough. Only through 
clinical studies using samples obtained by bronchoscopy with 
bronchoalveolar lavage do we know that this condition is char-
acterized by neutrophil-rich sputum that is culture positive for 
bacterial pathogens (33).
Chronic suppurative lung disease (CSLD) is a broad descriptive 
term, but it has recently been specifically applied to children who 
clinically appear to have bronchiectasis but do not demonstrate 
the diagnostic imaging features of bronchiectasis. Children with 
CSLD respond to the same treatment regimens used for childhood 
bronchiectasis, and some authors consider them a spectrum of 
the same disorder. Of note, they differ from children with PBB in 
that their conditions cannot be completely reversed with multiple 
courses of antibiotics. In a 2-year prospective study, 43% of 161 
children with PBB had >3 episodes of wet cough per year despite 
antibiotic treatment (32). The number of treatment failures that 
constitutes a change in diagnosis from PBB to CSLD has not 
been defined. Thirteen percent of children with PBB eventually 
demonstrated radiographic evidence of bronchiectasis (32). PBB 
and CSLD likely represent a continuum of chronic suppurative 
airway disease and recurrent treatment “failure” of children with 
PBB should raise the question of CSLD or bronchiectasis.
GLObaL DiSPaRiTieS iN SuPPuRaTive 
CHiLDHOOD LuNG DiSeaSe
There remain glaring disparities among children in different soci-
eties who are at risk for CSLD. Access to vaccines for Haemophilus 
type b, pneumococci, and influenza, and comprehensive longitu-
dinal health care vary significantly across and within countries. 
Among wealthy nations with effective public health infrastructures 
and proactive well-child care, suppurative lung disease is uncom-
mon and usually occurs in the context of a known pulmonary or 
immune host defense disorder. However, among high-risk indig-
enous groups in Australia, New Zealand, Argentina, and Alaska, 
postinfectious bronchiectasis is most common. There is ongoing 
debate about the relative role of social and environmental risks 
versus immune deficiencies and abnormal lung injury and repair 
processes in different populations of children (16, 34, 35). It is of 
interest that a high rate of consanguinity has reported in several 
series of families whose children have idiopathic bronchiectasis, 
suggesting a genetic predisposition to bronchiectasis in some 
groups (36, 37).
The global burden of CSLD in children is unknown. The geo-
graphic prevalences of bronchiectasis are limited due in part to 
lack of access to imaging technology need to make the diagnosis. 
Those regions where prevalences of acute pneumonia, tubercu-
losis, HIV infections, malnutrition, and tobacco and biomass 
combustion are highest are likely to be the regions where CSLD 
is more frequent. Figures 1–5 depict the variations in frequencies 
of risk factors across countries and geographic regions. The world 
map of episodes per child year of acute pneumonia reported in 
2007 is depicted in Figure 1 (38). Figure 2 is a map of worldwide 
cigarette consumption (# cigarettes smoked per person per year 
for individuals >15  years of age) according to the Tobaccos 
Atlas in 2015 (39). The percentage of households using solid 
fuel (biomass) for cooking in 2000 is depicted in Figure 3 (40). 
Figure 4 illustrates the global percentage of children <5 years old 
in 2005 who are underweight, a reflection of malnutrition (41). 
If these maps are superimposed, the highest risk for CSLD in 
children would occur in Southeast Asia, China, and Sub-Saharan 
Africa. Prevalence data about persistent suppurative lung condi-
tions in children in most of these areas have not been reported.
Tuberculosis in children with and without HIV is also global 
concern. Several reports of chest CT findings in children with 
tuberculosis describe bronchiectasis occurring in 9–20% and 
cavitary lesions in 25% of adolescents (42, 43). The Global 
Tuberculosis Programme at the World Health Organization 
estimated that 1 million children developed tuberculous disease 
in 2014 (44). Seventy-five percent of children with tuberculosis 
come from just 22 countries. Of these, India alone accounts to 
27% of the global burden of tuberculosis in children <15 years 
of age (45). The global frequency of tuberculosis cases per 
100,000 population in 2007 is portrayed in Figure 5 (46). The 
map of HIV disease prevalences also compiled by the World 
Health Organization in 2007 is portrayed in Figure  6 (47). 
These maps suggest that bronchiectasis related to tuberculosis 
and HIV occurs most frequently in Africa, India, and parts of 
Southeast Asia.
LONG-TeRM CONSeQueNCeS OF 
SuPPuRaTive LuNG DiSeaSe
Most children with acute suppurative processes, e.g., pneumonia, 
empyema, abscess, if treated appropriately, make full recoveries 
with minimal long-term morbidity. However, apart from CF, the 
long-term consequences of CSLD in children have not been well 
described. Serial lung function trends for children with CF and 
non-CF postinfectious bronchiectasis have been reported (48). 
Non-CF bronchiectasis is associated with worse lung function 
early in life soon after the initial airway injury, but it progresses 
much more slowly over time compared to CF-related bronchiec-
tasis. Complete resolution of symptoms among Native Alaskan 
children with postinfectious bronchiectasis occurs in one-third 
by adolescence (49). Although the mortality risk is greater in 
adults with bronchiectasis than among adults with asthma, it is 
lower compared to adults with COPD, at least in developed coun-
tries (50). Among adults with COPD, mortality is higher when 
it bronchiectasis is also present. Systems of care that transition 
youth and young adults with CSLD to adult providers have been 
best developed for patients with CF and, more recently, for those 
with ciliary disorders. Comprehensive care models of non-CF-
related bronchiectasis have been developed that stabilize and/or 
improve lung function over time (51). However, the impact of 
smoking tobacco and other combustible products among adoles-
cents and young adults with bronchiectasis has not been reported. 
Also, these models have not accounted for eventual transitions 
to adult care.
CONCLuSiON
With the advent of antibiotics, improved nutrition, and focus 
on child health in developed countries, bronchiectasis has been 
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termed an “orphan disease.” Relative to the research devoted to 
CF, the published research on care of children with other chronic 
suppurative respiratory disease is scarce. Although the World 
Health Organization has prioritized asthma, acute pneumonia, 
and tobacco use, the burden of CSLD in children is unknown. 
Given the geographic distribution of risk factors worldwide, it 
is likely that children with these conditions are underdiagnosed 
and undertreated. The global burden of CSLD in children and its 
impact on health in adulthood are important to ascertain. Only 
then can effective systems of comprehensive longitudinal care in 
the context of different cultures be devised.
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